|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INKINE PHARMACEUTICAL CO INC, 10-K, EX-23.1, 2000-09-26 |
Next: MILEMARKER INTERNATIONAL INC, PRE 14A, 2000-09-26 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) THE
ACCOMPANYING FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH (B) FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000929547
<NAME> INKINE PHARMACEUTICAL
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 5,629
<SECURITIES> 10,396
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 16,103
<PP&E> 513
<DEPRECIATION> 181
<TOTAL-ASSETS> 16,435
<CURRENT-LIABILITIES> 1,561
<BONDS> 0
0
0
<COMMON> 3
<OTHER-SE> 14,871
<TOTAL-LIABILITY-AND-EQUITY> 16,435
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 10,072
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 39
<INCOME-PRETAX> (9,712)
<INCOME-TAX> 0
<INCOME-CONTINUING> (9,712)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (9,712)
<EPS-BASIC> (.36)
<EPS-DILUTED> (.36)
</TABLE>
|
|